SION — Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: US
• Exchange: NASDAQ
• Employees: 41
• Website: https://www.sionnatx.com

Latest SEC filings for SION

• SCHEDULE 13D/A — 2026-09-21
• 8-K — 2026-08-10
• 10-Q — 2026-08-06
• 8-K — 2026-08-06
• 8-K — 2026-06-18
• SCHEDULE 13G/A — 2026-05-15
• SCHEDULE 13G/A — 2026-05-12
• 8-K — 2026-05-12
• 10-Q — 2026-05-12
• ARS — 2026-04-27

Latest SION news

• 2026-10-12 — Sionna Therapeutics, Inc. (SION) Loses 37.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (zacks.com)
• 2026-10-08 — Sionna Therapeutics, Inc. (NASDAQ:SION) Stock Has Average Target Price of $42.33 According to Brokerages (defenseworld.net)
• 2026-10-06 — INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION (globenewswire.com)
• 2026-10-01 — INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION (prnewswire.com)
• 2026-09-30 — IONNA Ranked #1 in JD Power Study as Network More than Doubles Size During 2026 (prnewswire_financial)
• 2026-09-29 — INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION (globenewswire.com)

Abrir análisis completo

Educational tool only — not investment advice.